Thalidomide Survivors in U.S. Seek Greater Recognition Amidst Claims of Undercounted Numbers
Children in the United States born with birth defects linked to thalidomide, administered unknowingly to their mothers in the 1950s and 1960s, are seeking recognition. There is a claim that the number of survivors in the U.S. is higher than…
Baltimore, MD, September 26, 2026 — Survivors of birth defects linked to the drug thalidomide, administered unknowingly to mothers in the United States during the 1950s and 1960s, are advocating for increased recognition. These individuals, born with severe congenital abnormalities attributed to prenatal exposure to the medication, are raising concerns about the historical acknowledgment of their cases.
Thalidomide was prescribed as a sedative and anti-nausea medication in the late 1950s and early 1960s. Its teratogenic effects, meaning it could cause birth defects, became apparent when a significant number of babies were born with limb malformations, and other severe physical anomalies. While the drug was withdrawn from the market, its impact on those born during that period continues to be felt.
A key aspect of the current movement among U.S. survivors is the assertion that the official count of individuals affected by thalidomide in the United States may be lower than the actual number. Advocates suggest that the government’s acknowledgement of the extent of thalidomide’s impact does not fully reflect the reality of survivors living with its consequences. The specific details regarding the methodology or evidence supporting this claim of an undercount have not been provided.
The quest for recognition encompasses a desire for greater awareness of the long-term health, social, and economic challenges faced by thalidomide survivors. The specific organizations or individuals leading this advocacy effort were not detailed in the available summary, nor were the particular actions they are taking to seek this recognition beyond the stated aim.
The historical context of thalidomide is a critical element in understanding the current situation. Many mothers who took the drug were unaware of its potential dangers to their unborn children. The drug was eventually banned in many countries, including the United States, after its devastating effects were documented. However, for those born before or during the period of its availability and subsequent withdrawal, the legacy of thalidomide remains a significant part of their lives.
Story summarized from the original created by Tana Weingartner on www.npr.org, see more information here.
Media gallery
